

Learn about common and serious side effects of Bacitracin/Polymyxin B ophthalmic ointment, how to manage them, and when to contact your doctor right away.
If your doctor prescribed Bacitracin/Polymyxin B ophthalmic ointment for a bacterial eye infection, you're probably wondering what side effects to expect. The good news: this medication has been used for decades, and most people tolerate it well. But like any antibiotic, it can cause reactions — and some of them need immediate medical attention.
This guide covers the common side effects, the serious ones you shouldn't ignore, and practical tips for managing them.
Bacitracin/Polymyxin B is a combination antibiotic ointment that treats bacterial eye infections. It contains two active ingredients — Bacitracin Zinc and Polymyxin B Sulfate — that work together to kill bacteria. Bacitracin targets gram-positive bacteria, while Polymyxin B handles gram-negative bacteria, giving the combination broad-spectrum coverage.
You may know it by brand names like Polysporin Ophthalmic, AK-Poly-Bac, or Polycin. It's commonly prescribed for conditions like bacterial conjunctivitis (pink eye), blepharitis, and keratitis. For more details, see our complete guide on what Bacitracin/Polymyxin B is and how it works.
Most side effects of Bacitracin/Polymyxin B ophthalmic ointment are mild and temporary. They usually improve as your body adjusts to the medication or resolve once you finish the course of treatment.
These side effects usually don't require any special treatment and shouldn't cause alarm. If they persist beyond a few days or get noticeably worse, let your doctor know.
Serious side effects are uncommon with Bacitracin/Polymyxin B, but they can happen. Contact your doctor right away — or go to the emergency room — if you experience any of the following:
Some groups should take extra precautions with Bacitracin/Polymyxin B:
Bacitracin/Polymyxin B is classified as Pregnancy Category C, meaning it hasn't been well-studied in pregnant women. The good news is that topical and ophthalmic forms have minimal systemic absorption, so the risk is likely low. However, you should tell your doctor if you're pregnant or breastfeeding so they can weigh the benefits against any potential risks.
While pediatricians commonly prescribe ophthalmic antibiotics for children with bacterial eye infections, the safety and effectiveness of Bacitracin/Polymyxin B ophthalmic ointment hasn't been fully established in patients under 18. Your child's doctor will determine if it's the right choice based on the specific situation.
No special dose adjustments are needed for older adults. Since the medication is applied topically with minimal systemic absorption, age-related kidney or liver changes typically aren't a concern.
Both Bacitracin and Polymyxin B can be nephrotoxic (harmful to the kidneys) when given systemically. With the ophthalmic ointment, systemic absorption is minimal — but if you have severe kidney disease and are using other nephrotoxic medications, mention it to your doctor.
Here are practical tips for dealing with the most common side effects:
Bacitracin/Polymyxin B ophthalmic ointment is generally well-tolerated, and most side effects are mild and temporary. Blurred vision and brief stinging are the most common — and both are expected with any eye ointment.
The key thing to watch for is signs of an allergic reaction (severe itching, swelling, difficulty breathing) or symptoms that get worse instead of better after a few days. If either happens, contact your doctor promptly.
If you're having trouble finding Bacitracin/Polymyxin B at your pharmacy due to the current shortage, Medfinder can help you locate pharmacies that have it in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.